APPLICATION
ANDA063038
TYPE
ANDA
ORIGINAL APPROVAL
1991-01-11
LATEST ACTION
2014-04-24
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription
Products
ERYTHROMYCINPrescription
ERYTHROMYCIN 2% · SOLUTION · TOPICAL
Approval history
2014-04-24Labeling · Supplement 4AP
1992-01-10Labeling · Supplement 1AP
1991-01-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.